Menatetrenone [vitamin K2] may prevent hepatocellular carcinoma in women with viral cirrhosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1448, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Menatetrenone (Vitamin K 2 ) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases: Meta-Analysis of Three Randomized, Controlled Trials

By Iwamoto Jun   Matsumoto Hideo   Takeda Tsuyoshi  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 471-479

Adis International

Access to resources Recommend Favorite

Main Characteristics of Hepatocellular Carcinoma and Cirrhosis and Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 1007-1011

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma

By Feitelson Mark A   Clayton Marcia M   Reis Helena MGPV   Wu Guoyi   Lu Eva Ping  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2233-2245

Informa Healthcare

Access to resources Recommend Favorite

HRT may prevent Alzheimer's disease in elderly women

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3485-3493

Blackwell Publishing

Access to resources Recommend Favorite